Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

2.

Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States.

Smith MJ, Ellenberg SS, Bell LM, Rubin DM.

Pediatrics. 2008 Apr;121(4):e836-43. doi: 10.1542/peds.2007-1760.

PMID:
18381512
3.

Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.

Crawley J, Sismanidis C, Goodman T, Milligan P; WHO Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization in infants receiving Intermittent Preventive Treatment for malaria..

Lancet. 2012 Sep 15;380(9846):1001-10. doi: 10.1016/S0140-6736(12)60775-2.

PMID:
22850358
4.

Lessons from an online debate about measles-mumps-rubella (MMR) immunization.

Nicholson MS, Leask J.

Vaccine. 2012 May 28;30(25):3806-12. doi: 10.1016/j.vaccine.2011.10.072.

PMID:
22063388
5.

Individual and community risks of measles and pertussis associated with personal exemptions to immunization.

Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE.

JAMA. 2000 Dec 27;284(24):3145-50.

PMID:
11135778
6.

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidelines for adults.

Hendriksz T, Malouf P, Foy JE; Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention..

J Am Osteopath Assoc. 2011 Oct;111(10 Suppl 6):S10-2.

PMID:
22086887
7.

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.

France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R; Vaccine Safety Datalink Team..

Pediatrics. 2008 Mar;121(3):e687-92. doi: 10.1542/peds.2007-1578.

PMID:
18310189
8.

Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles.

Salmon DA, Haber M, Gangarosa EJ, Phillips L, Smith NJ, Chen RT.

JAMA. 1999 Jul 7;282(1):47-53. Erratum in: JAMA 2000 May 3;283(17):2241.

PMID:
10404911
9.

Timing of measles immunization and effective population vaccine coverage.

Bielicki JA, Achermann R, Berger C.

Pediatrics. 2012 Sep;130(3):e600-6. doi: 10.1542/peds.2012-0132.

10.

Measles epidemiology and outbreak response immunization in a rural community in Peru.

Sniadack DH, Moscoso B, Aguilar R, Heath J, Bellini W, Chiu MC.

Bull World Health Organ. 1999;77(7):545-52.

11.

Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.

Verma R, Khanna P, Bairwa M, Chawla S, Prinja S, Rajput M.

Hum Vaccin. 2011 Oct;7(10):1109-11. Review.

PMID:
22238787
13.

Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.

Gans HA, Yasukawa LL, Sung P, Sullivan B, DeHovitz R, Audet S, Beeler J, Arvin AM.

J Infect Dis. 2013 Feb 15;207(4):574-82. doi: 10.1093/infdis/jis719.

14.

Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.

Dai B, Chen ZH, Liu QC, Wu T, Guo CY, Wang XZ, Fang HH, Xiang YZ.

Bull World Health Organ. 1991;69(4):415-23.

15.
16.
17.

International measles incidence and immunization coverage.

Hall R, Jolley D.

J Infect Dis. 2011 Jul;204 Suppl 1:S158-63. doi: 10.1093/infdis/jir124.

18.

Alternative routes of measles immunization: a review.

Cutts FT, Clements CJ, Bennett JV.

Biologicals. 1997 Sep;25(3):323-38. Review.

PMID:
9325001
19.

Benefits, risks and costs of immunization for measles, mumps and rubella.

White CC, Koplan JP, Orenstein WA.

Am J Public Health. 1985 Jul;75(7):739-44.

20.

Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.

Lin WH, Griffin DE, Rota PA, Papania M, Cape SP, Bennett D, Quinn B, Sievers RE, Shermer C, Powell K, Adams RJ, Godin S, Winston S.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2987-92. doi: 10.1073/pnas.1017334108.

Items per page

Supplemental Content

Support Center